Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06A ANTIDEPRESSANTS
N06AX Other antidepressants
N06AX24 Vilazodone
D09699 Vilazodone hydrochloride (USAN) <US>
USP drug classification [BR:br08302]
Antidepressants
SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
Vilazodone
D09699 Vilazodone hydrochloride (USAN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01639 CYP2C19 substrate
DG00964 Vilazodone
D09699 Vilazodone hydrochloride
DG01644 CYP2D6 substrate
DG00964 Vilazodone
D09699 Vilazodone hydrochloride
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00964 Vilazodone
D09699 Vilazodone hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Serotonin
HTR1A
D09699 Vilazodone hydrochloride (USAN) <US>
Transporters
Solute carrier family
SLC6
SLC6A4 (HTT)
D09699 Vilazodone hydrochloride (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09699
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09699
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09699
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01639 CYP2C19 substrate
DG00964 Vilazodone
DG01644 CYP2D6 substrate
DG00964 Vilazodone
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00964 Vilazodone